CDSCO bans use of Chlorpheniramine Maleate IP 2mg and Phenylephrine HCL IP 5mg drop/ml FDC in kids below 4 years Ruchika Sharma21 Dec 2023 2:19 PM ISTNew Delhi: To ensure the safety of infants and young children in the country, the Central Drugs Standard Control Organization (CDSCO) has...
JB Pharma enters Opthalmology space, signs Rs 1,089 crore deal with Novartis for 10 brands Ruchika Sharma20 Dec 2023 11:14 AM ISTNew Delhi: JB Chemicals & Pharmaceuticals Ltd (JB Pharma) has announced that the Company has inked a trade mark licence agreement along with...
Conduct BE study and clinical trial: CDSCO Panel tells Cipla on Formoterol Fumarate Dihydrate, glycopyrronium inhaler Dr. Divya Colin19 Dec 2023 6:58 PM ISTNew Delhi: Rejecting the proposal for clinical trial and bioequivalence (BE) study waiver presented by drug major Cipla, the Subject Expert Committee...
Shweta Rai takes over as MD of Bayer Zydus Pharma Ruchika Sharma18 Dec 2023 6:05 PM ISTPrior to this, she worked with companies of repute like Johnson & Johnson, MSD Pharmaceuticals, IQVIA and Pfizer.
AstraZeneca gets CDSCO panel nod to study anti-cancer drug Capivasertib Dr. Divya Colin17 Dec 2023 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Sun Pharma gets CDSCO panel nod to manufacture, and market Etifoxine HCL capsules for anxiety Susmita Roy16 Dec 2023 6:00 PM ISTNew Delhi: The drug major Sun Pharmaceuticals has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Fake Pharmacy Certificates Scam: Nine Chemists, 2 Ex-Registrars, 1 superintendent of Punjab State Pharmacy Council arrested Barsha Misra15 Dec 2023 3:41 PM ISTChandigarh: Unveiling a fake pharmacy certificates scam, the Punjab Vigilance Bureau (VB) on Tuesday arrested nine persons who allegedly obtained...
AstraZeneca gets CDSCO panel Nod to study anti-cancer drug Volrustomig in women with cervical cancer Dr. Divya Colin14 Dec 2023 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel revises warning statement of Sanofi's antidiabetic FDC Insulin Glargine plus Lixisenatide Dr. Divya Colin13 Dec 2023 6:00 PM ISTNew Delhi: Approving the amendment in the warning statement for Sanofi's Fixed Ratio Combination of Insulin Glargine 100U/mL plus Lixisenatide 50...
Roche Gets CDSCO Panel Nod to Study anti-cancer Drug Inavolisib Dr. Divya Colin12 Dec 2023 6:00 PM ISTNew Delhi: The drug major Roche has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
AstraZeneca gets a CDSCO panel Nod To study Rilvegostomig Dr. Divya Colin11 Dec 2023 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Conduct Phase III CT: CDSCO Panel Tells Akum Pharmaceutical on Antidiabetic FDC Dr. Divya Colin10 Dec 2023 6:00 PM ISTNew Delhi: Rejecting the proposal for the clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
